Chronic lymphocytic leukemia (CLL), the most frequent adult leukemia in Western countries, is characterized by the expansion of mature CD5+ B cells in protective microenvironmental niches of secondary lymphoid organs (SLOs) and bone marrow (BM). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.